Massoud Saidijam

14PUBLICATIONS
42CO-AUTHORS
PsychophysiologyMolecular targetsPredictive and prognostic markersAgricultural molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 10, 2023
Association of MGLL Intronic C>T Single Nucleotide Polymorphism (rs782440) with Borderline Personality Disorder: A Case-Control Study.

Nazanin Hatami Bavarsad, Leila Jahangard, Masood Saidijam

|Jul 18, 2022
Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization.

Farnosh Darabi, Massoud Saidijam, Fatemeh Nouri

|Dec 30, 2021
The Effect of miR-145-5p, DANCR and NRAS Expression Levels on the Survival Rate of Colorectal Cancer Patients.

Fatemeh Bahreini, Masoud Saidijam, Saeid Afshar

|Dec 03, 2021
A brief review on DNA vaccines in the era of COVID-19.

Maryam Shafaati, Massoud Saidijam, Meysam Soleimani

|Aug 25, 2021
Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.

Hamed Manoochehri, Akram Jalali, Hamid Tanzadehpanah

|Jun 19, 2021
The potential renal toxicity of silver nanoparticles after repeated oral exposure and its underlying mechanisms.

Hamed Nosrati, Manijeh Hamzepoor, Maryam Sohrabi

Pageof 3

Frequent Collaborators

4 joint publications

Rezvan Najafi

2 joint publications

Meysam Soleimani

2 joint publications

Hamid Tanzadehpanah

2 joint publications

Fatemeh Nouri